Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Sze Ting Lee"'
Autor:
Rachel Koldej, Allison Barraclough, Sze Ting Lee, Huw Morgan, Nicholas Holzwart, Minu Koshy, Charmaine Smith, Geoff Chong, Michael Gilbertson, Colm Keane, Stephen Ting, Leonid Churilov, David Ritchie, Eliza A. Hawkes
Publikováno v:
HemaSphere, Vol 7, p e429662d (2023)
Externí odkaz:
https://doaj.org/article/7a665ad28913436a9ba38b1eafd40ba7
Autor:
Eng-Siew Koh, Mustafa Khasraw, Elizabeth H Barnes, Kyle M Walsh, Mark Rosenthal, Rodney J Hicks, Farshad Foroudi, Hui K Gan, Anna K Nowak, Dale L Bailey, Paul Roach, Arian Lasocki, Robyn Leonard, Roel Verhaak, Andrew M Scott, Alisha Moore, Bradford A Moffat, Clare Senko, Roslyn J Francis, Martin Ebert, Sze Ting Lee, Eddie Lau, Greg Fitt, Robert Coffey, Richard De Abreu Lourenco, Lucas Adda, Paul A Thomas, Michael Back
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Introduction Glioblastoma is the most common aggressive primary central nervous system cancer in adults characterised by uniformly poor survival. Despite maximal safe resection and postoperative radiotherapy with concurrent and adjuvant temozolomide-
Externí odkaz:
https://doaj.org/article/d8d21057c5584e9388379c1d9d0c188d
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 10, Iss 1, Pp 20-27 (2022)
Objective(s): 18F-FDG PET/CT is increasingly performed in patients with differen-tiated thyroid cancer. The aim of this study was to assess the clinical impact of 18F-FDG PET/CT on the management of patients with differentiated thyroid carcinoma who
Externí odkaz:
https://doaj.org/article/887a069ad0604d97a14f484351ca0ba9
Autor:
Sze Ting Lee, Niall Tebbutt, Hui Kong Gan, Zhanqi Liu, John Sachinidis, Kunthi Pathmaraj, Andrew Mark Scott
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionTumor hypoxia and angiogenesis are implicated in tumor growth and metastases, and anti-angiogenic therapies have an important role in treating patients with metastatic colorectal cancer. However, the prevalence of hypoxia has not been ful
Externí odkaz:
https://doaj.org/article/f8cf3dbca693425ca78964b7071b7db1
Autor:
Kerry E. Jewell, James A. Kuzich, Sze Ting Lee, Rebecca Trethowan, Richard Macdonell, Anthony P. Schwarer
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss , Pp 100341- (2021)
Externí odkaz:
https://doaj.org/article/5e0c5b1bf1be4fa1b07298e8c14480e2
Autor:
Peter K. Wong, Sze Ting Lee, Carmel Murone, John Eng, Nathan Lawrentschuk, Salvatore U. Berlangieri, Kunthi Pathmaraj, Graeme J. O'Keefe, John Sachinidis, Amanda J. Byrne, Damien M. Bolton, Ian D. Davis, Andrew M. Scott
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 2, Iss 1, Pp 3-11 (2014)
Objective(s): The ability to measure cellular proliferation non-invasively in renal cell carcinoma may allow prediction of tumour aggressiveness and response to therapy. The aim of this study was to evaluate the uptake of 18Ffluorothymidine (FLT) PET
Externí odkaz:
https://doaj.org/article/cab8e5155b144120aba430b682f6bc81
Autor:
Kate Manos, Geoffrey Chong, Colm Keane, Sze-Ting Lee, Charmaine Smith, Leonid Churilov, Joseph McKendrick, William Renwick, Piers Blombery, Melinda Burgess, Niles Elizabeth Nelson, Tineke Fancourt, Joanne Hawking, Wendi Lin, Andrew M. Scott, Allison Barraclough, Joel Wight, Andrew Grigg, Chun Yew Fong, Eliza A. Hawkes
Publikováno v:
Leukemia. 37:1092-1102
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:e190-e194
Autor:
Boktor, Raef R.1,2,3 raef.boktor@austin.org.au, Sze Ting Lee1,2,3, Berlangieri, Salvatore U.1, Scott, Andrew M.1,2,3,4
Publikováno v:
Asia Oceania Journal of Nuclear Medicine & Biology. Winter/Spring2022, Vol. 10 Issue 1, p20-27. 8p.
Autor:
Eliza A Hawkes, Jake Shortt, Greg Hapgood, Belinda A. Campbell, Dejan Radeski, Sze Ting Lee, Maya Latimer, Stephen Lade, Joshua W.D. Tobin, Henry Miles Prince, Bryone J. Kuss, D Purtill
Publikováno v:
Internal Medicine Journal. 52:1806-1817
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous disease group accounting for 10% of non-Hodgkin lymphomas. PTCL patients have typically poorer outcomes compared to aggressive B-cell lymphomas. However, such outcomes are heavily dependen